Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT03663127 Enrolling by invitation - Hypertension Clinical Trials

Evaluation of "Beauty Drink" on Regulation of Blood Pressure Effect by Clinical Trial

Start date: July 26, 2018
Phase: N/A
Study type: Interventional

This is the report to assess the effect of supplementation with gamma-aminobutyric acid on blood pressure among people with mild hypertension. Overall, "Beauty Drink" consumption for 8 weeks could successfully reduce mean diastolic and systolic BP through the suppression of ACE that is linked to downstream suppresion of angiotensin II formation, which further decreases the sympathetic outflow that leads to hypertension.

NCT ID: NCT03639480 Enrolling by invitation - Hypertension Clinical Trials

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Start date: October 13, 2017
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of CJ-30061 compared with amlodipine/valsartan combination therapy and valsartan/atorvastatin combination therapy in hypertensive patients with hyperlipidemia

NCT ID: NCT03637192 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of High Altitude on Cognitive Function

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to High Altitude (2500m above sea level) on cognitive functions

NCT ID: NCT03637179 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (2500m above sea level) on pulmonary artery pressure and right heart function (Echo) under exercise.

NCT ID: NCT03637166 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo)

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude ("Säntis"; 2500m above sea level) on pulmonary artery pressure and right heart function (echo)

NCT ID: NCT03637153 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure to High Altitude on Exercise Capacity

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to High Altitude (2500m above sea level) in constant loaded exercise capacity.

NCT ID: NCT03637140 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on pulmonary artery pressure and right heart function (echo) under exercise.

NCT ID: NCT03637127 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Cognitive Function

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on cognitive functions.

NCT ID: NCT03637114 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover trial in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on blood and tissue oxygenation (ABGA, near infrared spectroscopy)

NCT ID: NCT03637088 Enrolling by invitation - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo)

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on pulmonary artery pressure and right heart function (Echo).